Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the recipient of a significant growth in short interest in February. As of February 15th, there was short interest totalling 15,000 shares, a growth of 102.7% from the January 31st total of 7,400 shares. Based on an average trading volume of 1,150,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 1.1% of the company’s stock are short sold.
Arcadia Biosciences Stock Up 1.3 %
RKDA traded up $0.05 during trading on Friday, hitting $3.91. The company’s stock had a trading volume of 5,148 shares, compared to its average volume of 11,476. The business’s 50 day simple moving average is $5.05 and its 200-day simple moving average is $4.05. The firm has a market cap of $5.34 million, a PE ratio of -0.91 and a beta of 0.88. Arcadia Biosciences has a one year low of $1.85 and a one year high of $10.31.
Institutional Investors Weigh In On Arcadia Biosciences
A hedge fund recently bought a new stake in Arcadia Biosciences stock. Geode Capital Management LLC bought a new stake in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned approximately 0.90% of Arcadia Biosciences as of its most recent filing with the Securities & Exchange Commission. 17.73% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Report on Arcadia Biosciences
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
See Also
- Five stocks we like better than Arcadia Biosciences
- Trading Stocks: RSI and Why it’s Useful
- Chaos and Cash: Finding Opportunity in Volatility
- What is the NASDAQ Stock Exchange?
- Realty Income: An Anchor in Volatile Markets
- About the Markup Calculator
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
